NERV · Minerva Neurosciences, Inc.
$4.58
+0.66 (+16.84%)
At close · Aug 14
Market Cap
$218.68M
Shares
47.75M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-09 | — | $75,000,000 | $22,600,000 as of 2025-06-30 | — | 10-Q , filed 2026-08-07 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2017-12-31 | $389 | 10-K, filed 2019-03-12 |
Key facts
CIK
1598646
CUSIP
603380205
13F (30d)
57 filings
55 filers
Visit website
Investor relations